{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:44:18Z","timestamp":1793659458881,"version":"4.5.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":111,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PIGE-0052-2020"],"award-info":[{"award-number":["PIGE-0052-2020"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015883","name":"Sociedad Espa\u00f1ola de Nefrolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI17\/00130"],"award-info":[{"award-number":["PI17\/00130"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI17\/01495"],"award-info":[{"award-number":["PI17\/01495"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI20\/00375"],"award-info":[{"award-number":["PI20\/00375"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI20\/00487"],"award-info":[{"award-number":["PI20\/00487"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SAF2015-63696-R"],"award-info":[{"award-number":["SAF2015-63696-R"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.nefroe.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T04:50:26Z","timestamp":1635310226000},"page":"373-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sickle cell nephropathy. Clinical manifestations and new mechanisms involved in kidney injury"],"prefix":"10.1016","volume":"41","author":[{"given":"Salvador","family":"Pay\u00e1n-Pern\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ruiz Llobet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel Francisco","family":"Remacha Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Egido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Aurelio","family":"Ballar\u00edn Cast\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2021.10.001_bib0005","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood-2018-03-818161","article-title":"How I treat the older adult with sickle cell disease","volume":"132","author":"Thein","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0010","series-title":"Eritropatolog\u00eda","first-page":"309","article-title":"Hemoglobinopat\u00edas y talasemias","author":"Ropero Gradilla","year":"2017"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ncomms1104","article-title":"Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis","volume":"1","author":"Piel","year":"2010","journal-title":"Nat Commun"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0030","first-page":"30717","article-title":"Actualizaci\u00f3n del registro espa\u00f1ol de hemoglobinopat\u00edas de ni\u00f1os y adultos","volume":"S0025-7753","author":"Bard\u00f3n Cancho","year":"2020","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0035","unstructured":"Standards for Clinical Care of Adults with Sickle Cell Disease in the UK-2018. [Accessed 20 July 2020]. Available from: https:\/\/www.sicklecellsociety.org\/resource\/sicklecellstandards\/."},{"key":"10.1016\/j.nefroe.2021.10.001_bib0040","series-title":"Sociedad Espa\u00f1ola de Hematolog\u00eda y Oncolog\u00eda Pedi\u00e1tricas (SEHOP)","article-title":"Gu\u00eda de Pr\u00e1ctica Cl\u00ednica de la Enfermedad de C\u00e9lulas Falciformes","author":"Cela","year":"2019"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fphys.2020.00435","article-title":"Recent advances in the treatment of sickle cell disease","volume":"11","author":"Salinas Cisneros","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0050","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/ajh.24906","article-title":"A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy","volume":"92","author":"Estepp","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0055","article-title":"Hydroxyurea (hydroxycarbamide) for sickle cell disease","volume":"4","author":"Nevitt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0060","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2014-02-557439","article-title":"How I treat renal complications in sickle cell disease","volume":"123","author":"Sharpe","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneph.2015.8","article-title":"Sickle cell disease: renal manifestations and mechanisms","volume":"11","author":"Nath","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0070","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/17474086.2017.1395279","article-title":"The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait","volume":"10","author":"Naik","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0075","first-page":"591","article-title":"Afectaci\u00f3n renal en la enfermedad falciforme","volume":"31","author":"L\u00f3pez Revuelta","year":"2011","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0080","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/pbc.24100","article-title":"Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia","volume":"59","author":"Alvarez","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0085","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/M18-1161","article-title":"Clinical outcomes associated with sickle cell trait: a systematic review","volume":"169","author":"Naik","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF00862083","article-title":"Protracted, gross hematuria in sickle cell trait: response to multiple doses of 1-desamino-8-D-arginine vasopressin","volume":"10","author":"Moudgil","year":"1996","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/pbc.22295","article-title":"Low dose, oral epsilon aminocaproic acid for renal papillary necrosis and massive hemorrhage in hemoglobin SC disease","volume":"54","author":"Gabrovsky","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000019703","article-title":"Massive gross hematuria in a sickle cell trait patient with renal papillary necrosis. Conservative approach using a balloon ureteral catheter to tamponade the papilla bleeding","volume":"34","author":"Herard","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0105","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.08511109","article-title":"Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature","volume":"5","author":"Haymann","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0110","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9440(10)64037-0","article-title":"Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease","volume":"158","author":"Nath","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0115","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ajh.23817","article-title":"Hyperfiltration is associated with the development of microalbuminuria in patients with sickle cell anemia","volume":"89","author":"Vazquez","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1523-1755.2005.67097.x","article-title":"Pathways to nephron loss starting from glomerular diseases-insights from animal models","volume":"67","author":"Kriz","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MD.0b013e3181ca59b6","volume":"89","author":"Maigne","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0130","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ajh.23762","article-title":"The glomerulopathy of sickle cell disease","volume":"89","author":"Ataga","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000167444","article-title":"Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study","volume":"7","author":"Bakir","year":"1987","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0140","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.JIM.0000446836.75352.72","article-title":"Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease","volume":"62","author":"Gosmanova","year":"2014","journal-title":"J Investig Med"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0145","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","article-title":"American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease","volume":"3","author":"Liem","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0150","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","article-title":"Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure","volume":"17","author":"Guasch","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.21016","article-title":"Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency","volume":"83","author":"Gordeuk","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0160","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/ndt\/gfq083","article-title":"Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension","volume":"25","author":"Audard","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/039139889001300604","article-title":"Acute renal failure in sickle cell anemia","volume":"13","author":"Sklar","year":"1990","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0170","first-page":"153","article-title":"Glomerular function in sickle cell disease patients during crisis","volume":"23","author":"Aderibigbe","year":"1994","journal-title":"Afr J Med Med Sci"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0175","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2215\/CJN.01600211","article-title":"Chronic kidney disease and albuminuria in children with sickle cell disease","volume":"6","author":"McPherson Yee","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0180","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1751-553X.2008.01089.x","article-title":"The changing face of homozygous sickle cell disease: 102 patients over 60 years","volume":"31","author":"Serjeant","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5414\/CNP58009","article-title":"Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival","volume":"58","author":"Abbott","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0195","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/ndt\/gfs585","article-title":"Improved survival among sickle cell kidney transplant recipients in the recent era","volume":"28","author":"Huang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069922","article-title":"Determining glomerular filtration rate in homozygous sickle cell disease: utility of serum creatinine based estimating equations","volume":"8","author":"Asnani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bcmd.2014.07.018","article-title":"Cystatin C: a useful marker of glomerulopathy in sickle cell disease?","volume":"54","author":"Asnani","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0210","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2217\/bmm-2019-0105","article-title":"Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients","volume":"13","author":"Belis\u00e1rio","year":"2019","journal-title":"Biomark Med"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0220","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1172\/JCI115521","article-title":"Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait","volume":"88","author":"Gupta","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0225","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1681\/ASN.V1051014","article-title":"Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans","volume":"10","author":"Guasch","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0230","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(70)90836-6","article-title":"Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies","volume":"1","author":"Statius van Eps","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0235","first-page":"1","article-title":"Imaging of renal medullary carcinoma","volume":"4","author":"Greco","year":"2017","journal-title":"J Kidney Cancer VHL"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0240","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2215\/CJN.01970211","article-title":"AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences","volume":"7","author":"Moreno","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0245","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.molmed.2010.07.006","article-title":"Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design","volume":"16","author":"Buehler","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0255","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0260","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.bcmd.2014.12.001","article-title":"Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease","volume":"54","author":"Chintagari","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0265","first-page":"1044","article-title":"Hemopexin deficiency promotes acute kidney injury in sickle cell disease","volume":"135","author":"Ofori-Acquah","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0270","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/path.5011","article-title":"Podocytes are new cellular targets of haemoglobin-mediated renal damage","volume":"244","author":"Rubio-Navarro","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0275","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fphar.2019.00740","article-title":"Nrf2 plays a protective role against intravascular hemolysis-mediated acute kidney injury","volume":"10","author":"Rubio-Navarro","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nefroe.2021.10.001_bib0280","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.2174\/0929867324666170511120814","article-title":"Targeting Nrf2 in protection against renal disease","volume":"24","author":"Guerrero-Hue","year":"2017","journal-title":"Curr Med Chem"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251421000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251421000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:46:22Z","timestamp":1761853582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251421000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2013251421000912"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.10.001","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sickle cell nephropathy. Clinical manifestations and new mechanisms involved in kidney injury","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2020.10.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}